Holen Sie sich die Stockscreener-App
2.25
5.14%
0.11
Schlusskurs vom Vortag:
$2.14
Offen:
$2.19
24-Stunden-Volumen:
75,165
Relative Volume:
0.50
Marktkapitalisierung:
$62.99M
Einnahmen:
$1.82M
Nettoeinkommen (Verlust:
$-267.63M
KGV:
-0.1116
EPS:
-20.1639
Netto-Cashflow:
$-50.53M
1W Leistung:
+16.58%
1M Leistung:
+17.80%
6M Leistung:
-48.86%
1J Leistung:
-86.56%
1-Tages-Spanne:
$2.19
$2.38
1-Wochen-Bereich:
$1.90
$2.38
52-Wochen-Spanne:
$1.40
$19.56
Cibus Inc Stock (CBUS) Company Profile
Firmenname
Cibus Inc
Sektor
Branche
Telefon
(858) 450-0008
Adresse
6455 NANCY RIDGE DRIVE, SAN DIEGO
Vergleichen Sie CBUS mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
CBUS
Cibus Inc
|
2.25 | 62.99M | 1.82M | -267.63M | -50.53M | -20.16 |
|
VRTX
Vertex Pharmaceuticals Inc
|
501.15 | 126.96B | 11.02B | -535.60M | -978.00M | -2.20 |
|
REGN
Regeneron Pharmaceuticals Inc
|
605.61 | 65.06B | 14.09B | 4.50B | 2.96B | 39.28 |
|
ARGX
Argen X Se Adr
|
649.67 | 37.54B | 2.19B | 833.04M | -1.28B | 12.71 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
259.39 | 32.56B | 2.25B | -278.16M | -42.59M | -2.17 |
|
ONC
Beigene Ltd Adr
|
255.77 | 26.40B | 3.81B | -644.79M | -669.77M | -6.24 |
Cibus Inc Stock (CBUS) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2024-07-29 | Eingeleitet | Alliance Global Partners | Buy |
| 2024-07-19 | Fortgesetzt | Canaccord Genuity | Buy |
| 2023-10-09 | Eingeleitet | H.C. Wainwright | Buy |
| 2023-07-19 | Fortgesetzt | Canaccord Genuity | Buy |
Cibus Inc Aktie (CBUS) Neueste Nachrichten
Cibus director Prante sells $2,875 in stock - MSN
Cibus (CBUS) Expected to Announce Earnings on Thursday - MarketBeat
Cibus (CBUS) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release - Yahoo Finance
Geode Capital Management LLC Has $1.09 Million Holdings in Cibus, Inc. (NASDAQ:CBUS) - Defense World
USDA-APHIS Designates Cibus' Disease Resistance Traits for Gene-Edited Canola as Not Regulated - ISAAA.org
Press Release Distribution & PR Platform - ACCESS Newswire
Cibus to Report First Quarter 2025 Financial Results on May 8, 2 - GuruFocus
Cibus director Gerhard Prante sells shares worth $2,852 - MSN
Cibus director Gerhard Prante sells shares worth $2,932 - MSN
Cibus to Report First Quarter 2025 Financial Results on May 8, 2025 After the Market Close and Host Conference Call - The Manila Times
Cibus to Report First Quarter 2025 Financial Results on May 8, 2025 After the Market Close and ... - Leader-Telegram
Agricultural Biotech Leader Cibus Sets Q1 2025 Earnings Release: Key Gene Editing Updates Expected - Stock Titan
Cibus announces USDA-APHIS designated two products as not regulated - TipRanks
Cibus (CBUS) Canola Traits Receive USDA Non-Regulated Status | C - GuruFocus
USDA-APHIS Designates Additional Cibus' Disease Resistance Trait Products as Not Regulated | CBUS Stock News - GuruFocus
USDA-APHIS Designates Additional Cibus’ Disease Resistance Trait Products as Not Regulated - Leader-Telegram
USDA Approves Cibus Gene-Edited Canola Traits That Combat 50% Crop Loss | CBUS Stock News - Stock Titan
Cibus director Gerhard Prante sells $2,806 in stock - MSN
Cibus director Prante Gerhard sells $2,875 in stock - MSN
Raymond James Financial Inc. Invests $89,000 in Cibus, Inc. (NASDAQ:CBUS) - Defense World
17,744 Shares in Cibus, Inc. (NASDAQ:CBUS) Acquired by Sei Investments Co. - Defense World
Commonwealth Equity Services LLC Purchases Shares of 22,201 Cibus, Inc. (NASDAQ:CBUS) - Defense World
Canaccord cuts Cibus stock target to $18, maintains buy rating - MSN
Levi & Korsinsky Announces an Investigation on Behalf of Cibus, Inc. (CBUS) Shareholders Who May Have Been Affected by Fraud - ACCESS Newswire
Corient Private Wealth LLC Sells 60,000 Shares of Cibus, Inc. (NASDAQ:CBUS) - Defense World
Charles Schwab Investment Management Inc. Sells 7,726 Shares of Cibus, Inc. (NASDAQ:CBUS) - Defense World
Cibus stock plunges to 52-week low, hits $1.8 amid sharp decline - Investing.com Australia
Research Analysts Offer Predictions for Cibus Q1 Earnings - MarketBeat
HC Wainwright Reiterates Buy Rating for Cibus (NASDAQ:CBUS) - MarketBeat
Cibus outlines advanced gene editing initiatives with potential revenue milestones by 2026 - MSN
What is HC Wainwright’s Forecast for Cibus Q1 Earnings? - Defense World
Cibus (NASDAQ:CBUS) Earns Buy Rating from HC Wainwright - Defense World
Cibus, Inc. (NASDAQ:CBUS) Q4 2024 Earnings Call Transcript - Insider Monkey
Cibus, Inc. Earnings Call: Strategic Progress Amid Challenges - TipRanks
Cibus (NASDAQ:CBUS) Posts Earnings Results, Misses Estimates By $0.19 EPS - MarketBeat
Cibus Inc (CBUS) Q4 2024 Earnings Call Highlights: Strategic Advances and Financial Insights - Yahoo Finance
Cibus Inc (CBUS) Q4 2024 Earnings Call Highlights: Strategic Adv - GuruFocus
Cibus, Inc. Reports Progress in Gene Editing and Financial Results - TipRanks
Cibus: Q4 Earnings Snapshot - mySA
Earnings call transcript: Cibus Inc. Q4 2024 focuses on innovation and cost-saving - Investing.com India
Cibus Inc reports results for the quarter ended December 31Earnings Summary - TradingView
Cibus: Q4 Earnings Snapshot -March 20, 2025 at 06:00 pm EDT - MarketScreener
Cibus Inc. (CBUS) reports earnings - Quartz
Cibus Reports Fourth Quarter Financial Results And Provides Business Update -March 20, 2025 at 04:54 pm EDT - Marketscreener.com
Finanzdaten der Cibus Inc-Aktie (CBUS)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.47%
2.63%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):